CHD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Church & Dwight Co Inc (CHD) is not a strong buy at the moment for a beginner investor with a long-term focus. While the stock has some positive indicators such as hedge fund buying and stable technicals, the negative catalysts, including declining net income, cautious analyst sentiment, and rising input costs, outweigh the positives. The lack of strong proprietary trading signals and the absence of significant congress trading data further support a hold recommendation.
The technical indicators show a neutral to slightly bullish trend. The MACD is above 0 and positively contracting, suggesting mild bullish momentum. RSI is neutral at 47.866, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock's price is close to the pivot point ($94.345), indicating limited immediate upside potential.
Hedge funds are buying significantly, with a 2536.43% increase in buying activity over the last quarter.
The company's gross margin increased by 2.46% YoY in Q4 2025, indicating improved operational efficiency.
Defensive consumer staples stocks are gaining attention due to falling consumer confidence.
Rising oil prices have increased input costs, creating concerns about future performance.
Analysts have lowered price targets recently, with some expressing caution about the sustainability of margins and dividends.
Q4 2025 financials showed a 24.15% YoY drop in net income and a 21.05% YoY decline in EPS, reflecting profitability challenges.
In Q4 2025, Church & Dwight reported a 3.93% YoY increase in revenue to $1.6442 billion. However, net income dropped by 24.15% YoY to $143.5 million, and EPS fell by 21.05% YoY to $0.60. Gross margin improved by 2.46% YoY to 45.85%, but overall profitability remains under pressure.
Recent analyst ratings are mixed to negative. Barclays downgraded the stock to Underweight with a price target of $80, citing caution in the consumer staples sector. RBC Capital and Wells Fargo maintain Outperform and Overweight ratings but have lowered price targets to $112 and $105, respectively. UBS and TD Cowen have Neutral and Hold ratings, with reduced price targets reflecting concerns about inflationary pressures and input costs.
